223 related articles for article (PubMed ID: 23883806)
1. Comparison of the nasal release of IL-4, IL-10, IL-17, CCL13/MCP-4, and CCL26/eotaxin-3 in allergic rhinitis during season and after allergen challenge.
Baumann R; Rabaszowski M; Stenin I; Tilgner L; Scheckenbach K; Wiltfang J; Schipper J; Chaker A; Wagenmann M
Am J Rhinol Allergy; 2013; 27(4):266-72. PubMed ID: 23883806
[TBL] [Abstract][Full Text] [Related]
2. Single dose topical corticosteroid inhibits IL-5 and IL-13 in nasal lavage following grass pollen challenge.
Erin EM; Leaker BR; Zacharasiewicz AS; Higgins LA; Williams TJ; Boyce MJ; de Boer P; Durham SR; Barnes PJ; Hansel TT
Allergy; 2005 Dec; 60(12):1524-9. PubMed ID: 16266385
[TBL] [Abstract][Full Text] [Related]
3. Nasal levels of soluble IL-33R ST2 and IL-16 in allergic rhinitis: inverse correlation trends with disease severity.
Baumann R; Rabaszowski M; Stenin I; Tilgner L; Gaertner-Akerboom M; Scheckenbach K; Wiltfang J; Chaker A; Schipper J; Wagenmann M
Clin Exp Allergy; 2013 Oct; 43(10):1134-43. PubMed ID: 24074331
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-8 secretion in patients with allergic rhinitis after an allergen challenge: interleukin-8 is not the main chemotactic factor present in nasal lavages.
Gosset P; Tillie-Leblond I; Malaquin F; Durieu J; Wallaert B; Tonnel AB
Clin Exp Allergy; 1997 Apr; 27(4):379-88. PubMed ID: 9146930
[TBL] [Abstract][Full Text] [Related]
5. Topical corticosteroid inhibits interleukin-4, -5 and -13 in nasal secretions following allergen challenge.
Erin EM; Zacharasiewicz AS; Nicholson GC; Tan AJ; Higgins LA; Williams TJ; Murdoch RD; Durham SR; Barnes PJ; Hansel TT
Clin Exp Allergy; 2005 Dec; 35(12):1608-14. PubMed ID: 16393327
[TBL] [Abstract][Full Text] [Related]
6. Eotaxin mRNA and protein expression in chronic sinusitis and allergen-induced nasal responses in seasonal allergic rhinitis.
Minshall EM; Cameron L; Lavigne F; Leung DY; Hamilos D; Garcia-Zepada EA; Rothenberg M; Luster AD; Hamid Q
Am J Respir Cell Mol Biol; 1997 Dec; 17(6):683-90. PubMed ID: 9409555
[TBL] [Abstract][Full Text] [Related]
7. Factors contributing to nasal allergic late phase eosinophilia.
Kramer MF; Jordan TR; Klemens C; Hilgert E; Hempel JM; Pfrogner E; Rasp G
Am J Otolaryngol; 2006; 27(3):190-9. PubMed ID: 16647984
[TBL] [Abstract][Full Text] [Related]
8. Eotaxin, but not IL-8, is increased in upper and lower airways of allergic rhinitis subjects after nasal allergen challenge.
Semik-Orzech A; Barczyk A; Wiaderkiewicz R; Pierzchała W
Allergy Asthma Proc; 2011; 32(3):230-8. PubMed ID: 21703102
[TBL] [Abstract][Full Text] [Related]
9. The kinetics of allergen-induced eotaxin level in nasal lavage fluid: its key role in eosinophil recruitment in nasal mucosa.
Terada N; Hamano N; Kim WJ; Hirai K; Nakajima T; Yamada H; Kawasaki H; Yamashita T; Kishi H; Nomura T; Numata T; Yoshie O; Konno A
Am J Respir Crit Care Med; 2001 Aug; 164(4):575-9. PubMed ID: 11520718
[TBL] [Abstract][Full Text] [Related]
10. Mucosal output of eotaxin in allergic rhinitis and its attenuation by topical glucocorticosteroid treatment.
Greiff L; Petersen H; Mattsson E; Andersson M; Erjefält JS; Linden M; Svensson C; Persson CG
Clin Exp Allergy; 2001 Aug; 31(8):1321-7. PubMed ID: 11529904
[TBL] [Abstract][Full Text] [Related]
11. Bet v 1-specific IgA increases during the pollen season but not after a single allergen challenge in children with birch pollen-induced intermittent allergic rhinitis.
Keen C; Johansson S; Reinholdt J; Benson M; Wennergren G
Pediatr Allergy Immunol; 2005 May; 16(3):209-16. PubMed ID: 15853949
[TBL] [Abstract][Full Text] [Related]
12. Effect of seasonal allergen exposure on mucosal IL-16 and CD4+ cells in patients with allergic rhinitis.
Pullerits T; Lindén A; Malmhäll C; Lötvall J
Allergy; 2001 Sep; 56(9):871-7. PubMed ID: 11551252
[TBL] [Abstract][Full Text] [Related]
13. Nasal fluid release of eotaxin-3 and eotaxin-2 in persistent sinonasal eosinophilic inflammation.
De Corso E; Baroni S; Battista M; Romanello M; Penitente R; Di Nardo W; Passali GC; Sergi B; Fetoni AR; Bussu F; Zuppi C; Paludetti G
Int Forum Allergy Rhinol; 2014 Aug; 4(8):617-24. PubMed ID: 24989688
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of nasal mucosal eotaxin in patients with allergic rhinitis during grass pollen season: effect of a local glucocorticoid.
Pullerits T; Lindén A; Praks L; Cardell LO; Lötvall J
Clin Exp Allergy; 2000 Oct; 30(10):1469-75. PubMed ID: 10998025
[TBL] [Abstract][Full Text] [Related]
15. [Humoral mucosal immunity in allergic rhinitis].
Kramer MF; Jordan TR; Pfrogner E; Rasp G
Laryngorhinootologie; 2005 Jul; 84(7):503-10. PubMed ID: 16010632
[TBL] [Abstract][Full Text] [Related]
16. Specificity and reproducibility of nasal biomarkers in patients with allergic rhinitis after allergen challenge chamber exposure.
Badorrek P; Müller M; Koch W; Hohlfeld JM; Krug N
Ann Allergy Asthma Immunol; 2017 Mar; 118(3):290-297. PubMed ID: 28284536
[TBL] [Abstract][Full Text] [Related]
17. Low levels of CC16 in nasal fluid of children with birch pollen-induced rhinitis.
Johansson S; Keen C; Ståhl A; Wennergren G; Benson M
Allergy; 2005 May; 60(5):638-42. PubMed ID: 15813809
[TBL] [Abstract][Full Text] [Related]
18. Evidence of maxillary sinus inflammation in seasonal allergic rhinitis.
Baroody FM; Mucha SM; deTineo M; Naclerio RM
Otolaryngol Head Neck Surg; 2012 Jun; 146(6):880-6. PubMed ID: 22301108
[TBL] [Abstract][Full Text] [Related]
19. Systemic up-regulation of TLR4 causes lipopolysaccharide-induced augmentation of nasal cytokine release in allergic rhinitis.
Ekman AK; Virtala R; Fransson M; Adner M; Benson M; Jansson L; Cardell LO
Int Arch Allergy Immunol; 2012; 159(1):6-14. PubMed ID: 22555057
[TBL] [Abstract][Full Text] [Related]
20. Nasal CpG oligodeoxynucleotide administration induces a local inflammatory response in nonallergic individuals.
Månsson A; Bachar O; Adner M; Cardell LO
Allergy; 2009 Sep; 64(9):1292-300. PubMed ID: 19243360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
